Patent Assignment
Reel/Frame 016673/0895
Document Re-Recorded to Correct Errors Contained in Property Number 10726326. Document Previously Recorded on Reel 015068 Frame 0876.
Recorded: 2005-08-29
Pages: 5
Assignee
SIRNA THERAPEUTICS, INC.
2950 WILDERNESS PLACE, BOULDER, COLORADO, 80301
Covered Property
(1)
Nucleic acid-based modulation of gene expression in the vascular endothelial growth factor pathway
Application:
10/726,236 →
Publication:
US 2004/0142895
Related Assignments
(1)
Other recorded transfers of the patent in this record — the chain of ownership.